John “Gabe” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking GLP-1s would come in with significant tendon injuries from relatively minor physical excursion.
Penn GLP-1 study finds small increase in risk of osteoporosis and gout
